ArticlePloS one2026
Viral dsRNA triggers human fetal membrane miR-146a-3p to be packaged into small extracellular vesicles which in turn drives inflammation through activation of Toll-like Receptor 7 and 8.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Interferon Regulatory Factors in Alcohol-Associated Liver Disease: Cell-Type Programs, Danger Signaling, and Therapeutic Opportunities.Current issues in molecular biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Maternal infection and chorioamnionitis are one of the leading causes of preterm birth and neonatal morbidity. The relationship and mechanisms linking bacterial infections and preterm labor are well researched, however, less is known about the mechanisms involved in how viral infections contribute to preterm labor. Previous work from our group demonstrated that following bacterial triggers, fetal membranes (FMs) express elevated miR-146a-3p which in turn acts as an intermediate danger signal by activating TLR8 to induce a robust inflammatory response. Using an established FM explant model system, the role of this and other TLR7/8-activating miRs in the propagation of viral-induced inflammation was investigated. Following exposure to the viral dsRNA mimic and TLR3 agonist, Poly(I:C), expression of FM tissue TLR7/8-activating miRs (miR-146a-3p, miR-21a, miR-29a, and Let7b) were not elevated. Despite this, in response to Poly(I:C), elevated FM secretion of pro-inflammatory IL-6 and IL-8, and IL-1β was TLR7- and TLR8-dependent. To investigate alternative methods of miR delivery, small extracellular vesicles (sEVs) from FM supernatants were isolated and found to contain elevated levels of miR-146a-3p and miR-21a under Poly(I:C) conditions. Furthermore, Poly(I:C)-induced IL-6 and IL-8 responses were reduced in the presence of an inhibitor of sEV biogenesis/release, and IL-6 and IL-1β production was reduced in the presence of a miR-146a-3p inhibitor. Together, these data suggests that sEVs produced from virally-stimulated human FMs contain and deliver elevated miR-146a-3p which acts as a danger signal to drive perpetuate inflammation via TLR7 and TLR8 activation. This work demonstrates a novel and important role for sEV packaged TLR7/8 activating-miR-146a-3p in FM inflammatory responses to viral infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.